PharmaShots | Incisive News in 3 Shots

Subscribe Now

Treat Esophageal Squamous Cell Carcinoma

BeiGene Reports NMPA's Acceptance of sBLA for Tislelizumab to Treat Esophageal Squamous Cell Carcinoma in China

BeiGene Reports NMPA's Acceptance of sBLA for Tislelizumab to Treat Esophageal Squamous Cell Carcinoma in China

July 8, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us